Utility Patent

A unanimous Supreme Court reversed the Federal Circuit and ended Amarin’s induced infringement suit against Hikma’s skinny-label generic of Vascepa, holding that anodyne marketing references to the branded drug do not plausibly allege that a generic maker actively encouraged infringing u

The Supreme Court denied certiorari in CAO Lighting’s challenge arguing that the Federal Circuit’s one-line Rule 36 affirmances of PTAB decisions violate the statutory mandate for judicial ‘opinions’ under Loper Bright principles.